Investment
Features
FeesSafety
Academy
More
Pluang+

Circle launches Arc blockchain to meet institutional standards and support AI-driven economy.

Protocol Fundamentals
16 Oct 2026
Tokenpost
View Source
Bullish
Circle launches Arc blockchain to meet institutional standards and support AI-driven economy.

Circle has developed the Arc blockchain designed specifically to meet the rigorous infrastructure standards required by financial institutions and to support an economy increasingly driven by autonomous AI agents. Existing blockchains were not built to handle real money and securities at institutional scale, prompting Circle to create a new platform that integrates lessons from open-source ecosystems and regulatory standards. Arc aims to enable central banks and financial institutions to operate with real money and investment contracts on-chain, while also preparing for a future where AI agents execute transactions and contracts autonomously.

Circle's new Arc blockchain is introduced amid a market where 41 of 50 major cryptocurrencies on Pluang rose today. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 16, 2026 22:02 WIB: ENJ (Enjin Coin) rose 4.78% to Rp538 with 80% sell orders, GRT (The Graph) increased 4.74% to Rp455 with 97% buy orders, and EGLD (MultiversX) gained 4.73% to Rp67,287 with 100% buy orders. This breadth indicates strong positive momentum across the sector.

More News

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...

Market News
Bullish
36 minutes ago
BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...

Market News
Neutral
1 hour ago
FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

Market News
Bullish
1 hour ago
K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

Market News
Bullish
1 hour ago
BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App